PROTAGONIST THERAPEUTICS INC

Ticker: PTGX CUSIP: 74366E102 Class: Common Stock

ROYCE & ASSOCIATES LP's Holding History (CIK: 0000906304)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 16,989 Value ($000) $1,484 Avg Close $81.85 Range $62.24 - $96.54

Q3 2025

Shares 16,989 Value ($000) $1,129 Avg Close $56.84 Range $49.38 - $68.26

Q2 2025

Shares 12,255 Value ($000) $677 Avg Close $47.99 Range $39.60 - $57.70

Q1 2025

Shares 12,255 Value ($000) $593 Avg Close $41.90 Range $33.70 - $60.60

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	16,989	$1,484	$81.85	$62.24 - $96.54
Q3 2025	16,989	$1,129	$56.84	$49.38 - $68.26
Q2 2025	12,255	$677	$47.99	$39.60 - $57.70
Q1 2025	12,255	$593	$41.90	$33.70 - $60.60